Product Information
TADALAFIL 2.5 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.1164 per EA under NDC 43547004703. Its NADAC has been published 178 times since Mar 29, 2023.
FDA first approved this application on Aug 11, 2022. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547004703
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TADALAFILApproval Type
Generic (ANDA)
FDA Application
ANDA210609FDA Approved
8/11/2022
TE Code
AB1
On Market Since
1/18/2022
Pharmacological Classes
Price Statistics
The NADAC for TADALAFIL 2.5 MG TABLET has been published 178 times since Mar 29, 2023, and over the history we have for it it has declined 41.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1164 per EA |
|---|---|
| All-time high | $0.2190 (Mar 13, 2024) |
| All-time low | $0.0828 (Jul 17, 2024) |
| 52-week high | $0.1298 |
| 52-week low | $0.1143 |
| Median price | $0.1284 |
| Average price | $0.1362 |
| Largest weekly change | +53.6% (Aug 21, 2024) |
| Weeks tracked | 178 |
| Tracking since | Mar 29, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TADALAFIL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 2.5 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.1164 per EA (NDC 43547004703), effective Aug 19, 2026.
How has the price of TADALAFIL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TADALAFIL 2.5 MG TABLET has declined 41.2%. It has been tracked across 178 weekly CMS publications since Mar 29, 2023.
What are the highest and lowest recorded NADAC prices for TADALAFIL 2.5 MG TABLET?
Since Mar 29, 2023, the NADAC for TADALAFIL 2.5 MG TABLET has ranged from a low of $0.0828 (Jul 17, 2024) to a high of $0.2190 (Mar 13, 2024), with a median of $0.1284 per EA.
Are there cheaper alternatives to TADALAFIL 2.5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TADALAFIL 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TADALAFIL 2.5 MG TABLET?
TADALAFIL 2.5 MG TABLET (NDC 43547004703) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.